Table 3.
Prognostic factors among patients with cirrhosis
| Characteristics | HR (95% CI) | P value |
|---|---|---|
| Model 1 | ||
| ALD vs. HBV | 2.43 (1.12–5.28) | 0.025 |
| ALD vs. HCV | 0.76 (0.51–1.12) | 0.165 |
| MELD score | 1.14 (1.10–1.19) | < 0.001 |
| ΔSMA/year ≤ − 3.1% | 3.68 (2.46–5.52) | < 0.001 |
| SATI ≤ 35.8 cm2/m2 | 1.70 (1.17–2.47) | 0.005 |
| Model 2 | ||
| ALD vs. HBV | 2.86 (1.30–6.29) | 0.009 |
| ALD vs. HCV | 0.89 (0.59–1.35) | 0.586 |
| ALBI score | 2.55 (2.01–3.24) | < 0.001 |
| ΔSMA/year ≤ − 3.1% | 3.73 (2.48–5.62) | < 0.001 |
| SATI ≤ 35.8 cm2/m2 | 1.55 (1.07–2.25) | 0.021 |
ALBI Albumin-bilirubin; ALD alcohol-associated liver disease; CI confidence interval; HBV hepatitis B virus; HCV hepatitis C virus; HR hazard ratio; MELD model for end-stage liver disease; SATI subcutaneous adipose tissue index; ΔSMA change in skeletal muscle area